Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

Presenter: Mitchell W. Krucoff

REGISTER for free or LOG IN to view this content

Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

We Recommend